Global Health Press
New HPV vaccine can prevent 80 percent of cervical cancers, research says

New HPV vaccine can prevent 80 percent of cervical cancers, research says

New research suggests that a recently developed human papillomavirus (HPV) vaccine can potentially prevent 80 percent of cervical cancers if it is administered before the child is 11 or 12 years old. HPV is a common sexually transmitted infection that can spread from one partner to another through vaginal, anal, or oral sex. And an estimated three-quarters of sexually active women are believed to have caught HPV at some point in their life. In the study, it was discovered that the new version of the 9-Valent vaccine — which guards against seven cancer-causing HPV strains — can potentially protect against 19,000 other cancers, including anal, oral, and penile. This advanced vaccine is also said to increase the protection from HPV-related cancers, including those of the vulva, from 71 to 92 percent; vagina, from 73 percent to 98 percent; the penis, 76 percent to 90 percent; and the anus, 87 percent to 96 percent. “This...

🔒 Premium Content - For Free

Unlock this content by becoming a Global Health Press subscriber. Join for exclusive articles, expert research, and valuable insights!

List of Abbreviation

Articles